Patents by Inventor Thomas Kissel

Thomas Kissel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions
    Patent number: 5593686
    Abstract: The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterized in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
    Type: Grant
    Filed: September 28, 1994
    Date of Patent: January 14, 1997
    Assignee: Sandoz Ltd.
    Inventors: Thomas Kissel, Henriette Schrank, Hans-Rainer Hoffmann
  • Sustained release formulations of water soluble peptides
    Patent number: 5538739
    Abstract: The invention discloses microparticles comprising a polypeptide, preferably somatostatin or an analog or derivative thereof, more preferably octreotide, in a polymeric matrix, preferably poly(lactide-co-glycolide) glucose. The invention also discloses sustained release formulations containing said microparticles and the use of said formulations in treating acromegaly and breast cancer.
    Type: Grant
    Filed: January 18, 1991
    Date of Patent: July 23, 1996
    Assignee: Sandoz Ltd.
    Inventors: David Bodmer, Jones W. Fong, Thomas Kissel, Hawkins V. Maulding, Jr., Oskar Nagele, Jane E. Pearson
  • Pharmaceutical compositions
    Patent number: 5364628
    Abstract: The present invention provides a pharmaceutical composition for the transdermal systemic administration of an active agent characterized in that the active agent is bopindolol or methysergide. Also the present invention provides a pharmaceutical composition for the transdermal systemic administration of a pharmacologically active agent characterized in that it contains bopindolol, tizanidine, clemastine, ketotifen or methysergide as active agent in a reservoir comprising a hydrophilic polymer. Furthermore a pharmaceutical composition for the transdermal systemic administration of pharmacologically active agents characterised in that the pharmacologically active agent is in a reservoir comprising a polyacrylate polymer containing cationic ester groups.
    Type: Grant
    Filed: October 22, 1993
    Date of Patent: November 15, 1994
    Assignees: Sandoz Ltd., LTS Lohmann Therapie-Systeme GmbH & Co.
    Inventors: Thomas Kissel, Henriette Schrank, Hans-Rainer Hoffmann
  • Planar therapeutic system, process for its production and utilization
    Patent number: 5132115
    Abstract: A transdermal therapeutic system is disclosed which comprises an optional flexible backing layer, one or more drug reservoir(s), one or more adhesive layer(s) and optionally a detachable protective layer for the skin contact surface of the flat therapeutical system. The skin contact area of the therapeutical system is a skin contact layer which has one or more non-adhesive drug-releasing section(s) and one or more skin-adhesion section(s), which optionally contain a further drug. A process is disclosed for the production of the system, as well as the use thereof for local or systemic, transdermal administration of drugs in human or veterinary medicine or in cosmetics.
    Type: Grant
    Filed: June 17, 1991
    Date of Patent: July 21, 1992
    Inventors: Karin Wolter, Fritz Herrmann, Hans R. Hoffmann, Gunter Simon, Thomas Kissel, Joerg Reinhardt
  • Interleukin therapy
    Patent number: 4863740
    Abstract: Interleukin-2 liposomes are advantageous sustained release formulations.
    Type: Grant
    Filed: May 12, 1988
    Date of Patent: September 5, 1989
    Assignee: Sandoz Ltd.
    Inventors: Thomas Kissel, Jurg Reinhardt, Henriette Schrank